MetLife Inc. (MET)
NYSE: MET
· Real-Time Price · USD
78.69
0.95 (1.22%)
At close: Aug 19, 2025, 3:59 PM
MetLife Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 17.16B | 18.57B | 18.66B | 18.44B | 17.82B | 16.06B | 19.03B | 15.87B | 16.62B | 15.39B | 16.32B | 22.28B | 15.47B | 15.4B | 20.09B | 16.91B | 19.59B | 15.56B |
Cost of Revenue | 12.64B | 13.54B | 13.58B | 12.85B | 13.1B | 11.41B | 15.85B | 13.21B | 14.1B | 13.08B | 12.51B | 18.86B | 12.5B | 11.46B | 16.56B | 12.89B | 12.1B | 13.21B |
Gross Profit | 4.52B | 4.74B | 4.8B | 5.41B | 4.38B | 4.49B | 3.17B | 2.66B | 2.52B | 2.31B | 3.8B | 3.42B | 2.98B | 3.94B | 3.53B | 4.02B | 7.49B | 2.35B |
Operating Income | 1.25B | 1.61B | 1.64B | 2.25B | 1.46B | 1.31B | 941M | 534M | 430M | 257M | 1.73B | 1.42B | 987M | 1.94B | 1.31B | 2.04B | 4.49B | 291M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 980M | 1.35B | 1.38B | 1.99B | 1.2B | 1.04B | 941M | 534M | 430M | 257M | 1.73B | 1.42B | 988M | 1.94B | 1.31B | 2.04B | 4.49B | 291M |
Net Income | 729M | 945M | 1.27B | 1.34B | 946M | 867M | 607M | 489M | 402M | 80M | 1.34B | 1.16B | 910M | 1.63B | 1.21B | 1.58B | 3.41B | 358M |
Selling & General & Admin | 1.54B | 1.56B | 1.51B | 1.49B | 1.48B | 1.51B | 1.65B | 1.54B | 1.5B | 1.48B | 1.57B | 1.44B | 1.43B | 1.43B | 1.65B | 1.4B | 1.3B | 1.42B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 2B | 1.82B | 1.79B | 1.92B | 1.58B | 1.81B | 581M | 580M | 591M | 575M | 508M | 569M | 557M | 577M | 577M | 573M | 1.7B | 642M |
Operating Expenses | 3.54B | 3.39B | 3.3B | 3.41B | 3.06B | 3.33B | 2.23B | 2.12B | 2.09B | 2.05B | 2.08B | 2B | 1.99B | 2B | 2.22B | 1.98B | 3B | 2.06B |
Interest Expense | 269M | 258M | 259M | 257M | 257M | 264M | 269M | 265M | 256M | 255M | 248M | 239M | 226M | 225M | 224M | 240M | 228M | 228M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 16.09B | 16.93B | 17B | 16.26B | 16.16B | 14.74B | 18.09B | 15.33B | 16.19B | 15.13B | 14.59B | 20.87B | 14.49B | 13.47B | 18.78B | 14.86B | 15.1B | 15.27B |
Income Tax Expense | 245M | 404M | 106M | 653M | 249M | 170M | 327M | 39M | 22M | 172M | 381M | 248M | 73M | 296M | 95M | 453M | 1.07B | -72M |
Shares Outstanding (Basic) | 670.8M | 682.3M | 696.07M | 699.3M | 710.5M | 723.2M | 745.45M | 751.4M | 765.9M | 769.18M | 779.1M | 795.8M | 809.7M | 830.5M | 838.1M | 854.9M | 873.3M | 878.31M |
Shares Outstanding (Diluted) | 675M | 687M | 697.9M | 703.7M | 714.7M | 728.4M | 745.46M | 755.5M | 769.6M | 781.2M | 790.2M | 800.7M | 814.5M | 830.5M | 845.2M | 861.2M | 879.7M | 892.1M |
EPS (Basic) | 1.04 | 1.29 | 1.78 | 1.82 | 1.28 | 1.11 | 0.77 | 0.56 | 0.48 | 0.02 | 1.69 | 1.38 | 1.09 | 1.91 | 1.40 | 1.78 | 3.85 | 0.33 |
EPS (Diluted) | 1.03 | 1.28 | 1.78 | 1.81 | 1.28 | 1.10 | 0.77 | 0.56 | 0.48 | 0.02 | 1.96 | 1.37 | 1.08 | 1.89 | 1.39 | 1.77 | 3.83 | 0.33 |
EBITDA | 1.25B | 1.61B | 1.64B | 2.25B | 1.46B | 1.31B | 1.21B | 799M | 686M | 512M | 1.98B | 1.65B | 1.21B | 2.16B | 1.53B | 2.28B | 4.71B | 519M |
EBIT | 1.25B | 1.61B | 1.64B | 2.25B | 1.46B | 1.31B | 1.21B | 799M | 686M | 512M | 1.98B | 1.65B | 1.21B | 2.16B | 1.53B | 2.28B | 4.71B | 519M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |